Bio-Rad Laboratories-B
- Market cap
- 9.76B
- P/E (TTM)i
- 44.47
- P/Bi
- 1.36
- EPSi
- 27.85
- Div yieldi
- 0.00%
- 52W posi
- 100%
Anonymous reader poll. Unscientific, not investment advice.
About Bio-Rad Laboratories-B
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
- Founded
- 1952
- CEO
- Mr. Norman Schwartz
- Employees
- 7,450
- Headquarters
- Hercules, California, United States of America
- Fiscal year end
- 12-31
- Website
- bio-rad.com
Company profile
- Exchange
- US
- Symbol
- BIO.B
- Market-cap rank
- #1492
- Listing date
- 1970-01-01
- Market cap
- 9.76B
- Float cap
- 7.70B
- Shares out
- 26.74M
- Float shares
- 21.10M
Sectors & themes
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.